Even for grade II meningiomas that show a high expression of SSTR2A, good expression was also seen for SSTR1 and 5, implying that PRRT targeting all SSTRs, but especially SSTR1, 2A, and 5, may be beneficial in delivering radiation to tumor cells more sufficiently. The gene discussed is SSTR1; the disease is meningioma.